Hyperactivation of the RAS/RAF/MEK/ERK cascade associated with Ras mutations is constantly observed in MM patients, of which approximately 23% carry Ras mutations, in particular K-Ras mutations, which correlate with poor prognosis in MM. Here, KRAS is linked to Miyoshi myopathy.